Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
11 studies found for:    Anticonvulsants | Open Studies | Chicago
Show Display Options
RSS Create an RSS feed from your search for:
Anticonvulsants | Open Studies | Chicago
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Pregnant Women Taking Lamictal for Bipolar Disorder
Condition: Bipolar Disorder
Intervention: Drug: lamotrigine
2 Recruiting A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications
Condition: Epilepsy
Interventions: Drug: Lacosamide Tablet;   Drug: Lasosamide Oral Solution;   Other: Placebo Tablet;   Other: Placebo Oral Solution
3 Recruiting A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome
Condition: Dravet Syndrome
Interventions: Drug: ZX008 - 0.2 mg/kg/day;   Drug: ZX008 - 0.4 mg/kg/day;   Drug: ZX008 - 30 mg/kg/day maximum dose;   Drug: Matching Placebo
4 Recruiting Once Daily Gabapentin in the Treatment of Post Amputation Pain
Conditions: Pain;   Quality of Life
Intervention: Drug: Gralise
5 Not yet recruiting Phase I Study of Safety and Tolerability of Acetazolamide With Temozolomide
Condition: Malignant Glioma of Brain
Interventions: Drug: Acetazolamide;   Drug: Temozolomide
6 Recruiting Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Condition: Lennox-Gastaut Syndrome (LGS)
Interventions: Drug: Perampanel;   Drug: Placebo
7 Recruiting The Effect of Magnesium on Maternal Mood, Cognitive Function, and Birth Experience
Condition: Depression, Postpartum
Intervention: Drug: Magnesium Sulfate
8 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Adenovirus;   Adrenal Insufficiency;   Airway Swelling;   Anesthesia;   Anxiety;   Anxiolysis;   Autism;   Autistic Disorder;   Bacterial Meningitis;   Bacterial Septicemia;   Benzodiazepine;   Bipolar Disorder;   Bone and Joint Infections;   Brain Swelling;   Central Nervous System Infections;   Convulsions;   Cytomegalovirus Retinitis;   Early-onset Schizophrenia Spectrum Disorders;   Edema;   Epilepsy;   General Anesthesia;   Gynecologic Infections;   Headaches;   Herpes Simplex Virus;   Hypertension;   Infantile Hemangioma;   Infection;   Inflammation;   Inflammatory Conditions;   Influenza;   Intra-abdominal Infections;   Lower Respiratory Tract Infections;   Migraines;   Pain;   Pneumonia;   Prophylaxis;   Schizophrenia;   Sedation;   Seizures;   Skeletal Muscle Spasms;   Skin and Skin-structure Infections;   Stable Angina;   Thromboprophylaxis;   Thrombosis;   Treatment-resistant Schizophrenia;   Urinary Tract Infection;   Withdrawal
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
9 Recruiting Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)
Condition: Cervical Spondylotic Myelopathy
Interventions: Drug: riluzole;   Drug: Placebo medication
10 Recruiting Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression
Condition: Bipolar Depression
Interventions: Drug: ITI-007;   Drug: Placebo
11 Recruiting A Study in Adults With Angelman Syndrome
Condition: Angelman Syndrome
Interventions: Drug: OV101 Regimen 1;   Drug: OV101 regimen 2;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.